Bomed Medical Manufacturing Ltd. said the federal Food and Drug Administration has approved the company's new Cardiodynamic Monitor, a computerized device now under development that will be used to measure the heart's efficiency.
Bomed is developing the instrument using its own funds and a grant from the National Aeronautics and Space Administration. NASA intends to use the device for astronaut testing before space flights.
As a diagnostic tool for hospital use, the Irvine-based maker of cardiovascular-monitoring instruments is rather enthused about the new instrument, which it expects will be complete and operational by mid-1987.
"The potential for this instrument to reduce the cost of health care and lower the physician and hospital liability could revolutionize the health-care industry," said Bo Sramek, chairman and chief executive.
Testing the various heart functions that would be measured by the Cardiodynamic Monitor now requires either the insertion of a catheter into the heart or other expensive procedures, Bomed said.
For the first six months of 1986, Bomed reported a net loss of $327,060 on revenue of $440,040.